Treatment of proliferative diseases with epothilone derivatives and radiation

Details for Australian Patent Application No. 2004218927 (hide)

Owner Novartis AG

Inventors Pruschy, Martin

Agent Davies Collison Cave

Pub. Number AU-A-2004218927

PCT Pub. Number WO2004/080458

Priority 0305928.4 14.03.03 GB

Filing date 12 March 2004

Wipo publication date 23 September 2004

International Classifications

A61K 031/427 - not condensed and containing further heterocyclic rings

A61P 035/00 Antineoplastic agents

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/080458 Priority application(s): WO2004/080458

6 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218929-Synergistically acting herbicidal mixtures

2004218923-Packaged film-covered tampon